Related Experiment Video

Updated: Jul 20, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome

J T Celebi1, K M Ward, M Wanner

  • 1Department of Dermatology, Columbia University, New York, USA. jt165@columbia.edu

Clinical and Experimental Dermatology
|January 25, 2005
PubMed

Insights

Atypical mole syndrome, linked to melanoma risk, was studied for genetic mutations. Researchers found no alterations in key genes, suggesting unknown genetic factors contribute to this condition.

Area of Science:

  • Genetics
  • Dermatology
  • Oncology

Background:

  • Atypical mole syndrome increases melanoma risk.
  • Known gene mutations (CDKN2A, ARF, CDK4, PTEN, BRAF) are linked to melanoma.
  • The genetic basis for atypical mole syndrome requires further investigation.

Purpose of the Study:

  • To investigate mutations in known melanoma-associated genes in patients with atypical mole syndrome.
  • To identify potential genetic susceptibility factors for atypical mole syndrome.

Main Methods:

  • Genetic analysis of 28 probands with atypical mole syndrome.
  • Sequencing of coding regions and splice junctions for CDKN2A, ARF, CDK4, PTEN, and BRAF genes.

Main Results:

  • No sequence alterations were found in the evaluated genes (CDKN2A, ARF, CDK4, PTEN, BRAF).
  • These genes are unlikely to be primary candidates for atypical mole syndrome.

Conclusions:

  • The study did not identify mutations in the investigated genes as causative for atypical mole syndrome.
  • Unknown genetic factors likely play a role in the development of atypical mole syndrome.
  • Further research is needed to uncover novel susceptibility genes.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...